Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05812092
Other study ID # ONRI-OP-001
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date May 1, 2021
Est. completion date March 1, 2025

Study information

Verified date April 2024
Source Research Source
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this study is to collect clinical and radiographic outcomes using the CONDUITâ„¢ Interbody Cervical System with supplemental fixation using a DePuy Synthes Cervical Plating System.


Description:

The primary aim of this study is to evaluate the performance of the CONDUITTM Interbody Cervical System in reducing pain and degree of disability as measured using the Neck Disability Index (NDI). Recruitment will occur from the patient population of the investigator. All patients will be evaluated for participation in the study by using the inclusion/exclusion listed below. Subjects need to meet all the inclusion and none of the exclusion. The responsibility is exclusively maintained by the investigator of any potential study participant as defined by the inclusion/ exclusion. Patients will consent to participating in the study, prior to any study procedures.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 50
Est. completion date March 1, 2025
Est. primary completion date March 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Male or female subject; at least 18 years of age 2. Diagnosis of radiculopathy or myelopathy with radiculopathy of the cervical spine, with pain, paresthesias or paralysis in a specific nerve root distribution C2 through T1, including at least one of the following: 1. Neck and/or arm pain of at least 30/100 mm on the visual analogue scale (VAS) scale 2. Decreased muscle strength of at least one level on the clinical evaluation (0 to 5) scale 3. Abnormal sensation including hyperesthesia or hypoesthesia; and/or 4. Abnormal reflexes 3. Symptomatic cervical disc disease, facet arthropathy, or cervical spinal stenosis at 1 or 2 levels between C2 and T1, suitable for treatment with anterior discectomy, decompression, and fusion 4. Radiographically determined pathology at the level to be treated correlating to primary symptoms including at least one of the following: 1. Decreased disc height on radiography,) in comparison to a normal adjacent disc 2. Degenerative spondylosis 3. Disc herniation 5. NDI Score >30%. 6. Unresponsive to non-operative, conservative treatment (rest, heat, electrotherapy, physical therapy, chiropractic care and/or analgesics) for: 1. Approximately six weeks from radiculopathy or myelopathy with radiculopathy symptom onset; or 2. Have the presence of symptoms or signs of nerve root/spinal cord compression despite continued non-operative, conservative treatment; or 3. Sooner than 6 weeks for worsening symptoms of neurologic compromise. 7. Reported to be medically cleared for surgery. 8. Physically and mentally able and willing to comply with the Protocol, including the ability to read and complete required forms and willing and able to adhere to the scheduled follow-up visits and requirements of the Protocol. 9. Signed informed consent provided by subject. Exclusion Criteria: 1. Have an active systemic infection or infection at the operative site. 2. Have a history of or anticipated treatment for active systemic infection, including HIV or Hepatitis C. 3. Have previous trauma to the C2 to T1 levels resulting in significant bony or disco- ligamentous cervical spine injury. 4. Have had any prior spine surgery at the operative level(s). 5. Have osteoporosis 6. Have Paget's disease of bone, osteomalacia or any other metabolic bone disease other than osteoporosis (addressed above). 7. Have active malignancy that included a history of any invasive malignancy (except non- melanoma skin cancer),unless the subject had been treated with curative intent and there had been no clinical signs or symptoms of the malignancy for at least five years. 8. Have symptomatic cervical disc disease or significant cervical spondylosis at more than 2 levels. 9. Have a known allergy to titanium. 10. Are currently pregnant or breastfeeding at time of enrollment or have plans to become pregnant within the next three years. 11. Have rheumatoid arthritis, lupus, or other autoimmune disease affecting the musculoskeletal system 12. Have diseases or conditions that would preclude accurate clinical evaluation in the opinion of the Investigator 13. Have concomitant conditions requiring daily, high-dose oral and/or inhaled steroids. High dose steroid use is defined as: 1. Daily, chronic use of oral steroids equivalent to 5 mg/day of prednisone or greater. 2. Daily, chronic use of inhaled corticosteroids (at least twice per day). 3. Use of short-term (less than 10 days) oral steroids at a daily dose greater than 40mg prednisone equivalent within one month of the study procedure. 14. Have current or recent history (within 1 year prior to screening) of substance abuse (alcoholism and/or narcotic addiction) requiring intervention. 15. Have a Body Mass Index (BMI) > 40 kg/m2. 16. Taking medications known to potentially interfere with bone/soft tissue healing (e.g., high-dose oral and/or inhaled steroids, immunosuppressant medication, chemotherapeutic agents). High dose steroid use as defined in Exclusion Criterion 13. 17. Have pending personal litigation relating to spinal injury (worker's compensation is not an exclusion). 18. Have a current history of heavy smoking (more than one pack of cigarettes per day). 19. Currently reside in a location, or anticipating a potential relocation, that may interfere with completion of follow-up examinations. 20. Have mental illness or belonged to a vulnerable population, as determined by the investigator (e.g., prisoner or developmentally disabled), that would compromise ability to provide informed consent or compliance with follow-up requirements. 21. Have an uncontrolled seizure disorder.

Study Design


Intervention

Device:
CONDUIT Interbody Cervical System with DePuy Synthes Cervical Plating System
CONDUIT Interbody Cervical System will be inserted between C2 through T1 and fixated using a DePuy Synthes Cervical Plating System at 1 or 2 levels.

Locations

Country Name City State
United States DFW Center for Spinal Disorders Fort Worth Texas

Sponsors (1)

Lead Sponsor Collaborator
Research Source

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary Outcome Measure: Number of participants with a 15% improvement in NDI score (based on 100% scale) compared to baseline 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06102304 - Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy N/A
Recruiting NCT06220799 - Impact of Craniovertebral Angle on Dizziness and Risk of Falling in Cervical Radiculopathy Patients
Completed NCT01944150 - Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis N/A
Recruiting NCT01495728 - Thoracic Manipulation in Patients With Cervical Radiculopathy N/A
Active, not recruiting NCT00695006 - Manual Therapy, Exercise and Traction for Patients With Cervical Radiculopathy: A RCT N/A
Completed NCT00344890 - Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy N/A
Completed NCT03382821 - Comparative Trial Via Tranforaminal Approach Versus Epidural Catheter Via Interlaminar Approach Phase 4
Completed NCT04915222 - Manual Cervical Traction and Natural Apophyseal Glides for Cervical Radiculopathy Patients N/A
Recruiting NCT06040047 - Prediction of Cervical Radiculopathy Success With PNF and Mobilization N/A
Recruiting NCT06043934 - Neural Mobilization With Intermittent Cervical Traction on Grip Strength, Sleep Quality, and Quality of Life in Cervical Radiculopathy N/A
Completed NCT04544683 - Effectiveness of Cervical Transforaminal Epidural Steroid Injection Phase 4
Active, not recruiting NCT03674619 - Cervical Radiculopathy Trial N/A
Completed NCT04597112 - Effect of Myofascial Release Technique In Patients With Unilateral Cervical Radiculopathy N/A
Active, not recruiting NCT06457529 - The Effect of Dry Needling and Prolotherapy on Pain, Function, and Quality of Life in Patients With Cervical Radiculopathy. N/A
Completed NCT04598113 - Effect of Cervical Traction on Balance in Cervical Radiculopathy Patients N/A
Recruiting NCT06339970 - Effects of Slider Versus Tensioners Nerve Gliding in Cervical Radiculopathy. N/A
Withdrawn NCT02694250 - Evaluation of Cervical Fusion With DTRAX® Cervical Cage With DTRAX Bone Screw N/A
Completed NCT02081456 - Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain N/A
Terminated NCT00308594 - Oral Dexamethasone for the Treatment of Cervical Radiculopathy Phase 2
Completed NCT05887427 - Acute Effect of Neural Mobilization in Cervical Radiculopathy: A Randomized Controlled Study N/A